Spinal Restoration has announced that the FDA has approved an investigational device exemption pilot study (15 patients)of the Biostat Disc Augmentation System. The system consists of Biostat Biologx Fibrin Sealant, a human derived, biologic tissue sealant, and a proprietary application system designed to safely deliver the biologic to the intervertebral disc. The Biostat Disc Augmentation System has been specifically developed to address chronic low back pain resulting from
degenerative cracks and fissures which form within the intervertebral
disc.
No Pingbacks for this post yet...
The healthcare industry is an ever-changing, ever-adapting environment. MET can help you ensure you are kept up to date by providing you with the latest industry news.
| Mon | Tue | Wed | Thu | Fri | Sat | Sun |
|---|---|---|---|---|---|---|
| << < | > >> | |||||
| 1 | 2 | 3 | 4 | 5 | 6 | 7 |
| 8 | 9 | 10 | 11 | 12 | 13 | 14 |
| 15 | 16 | 17 | 18 | 19 | 20 | 21 |
| 22 | 23 | 24 | 25 | 26 | 27 | 28 |
| 29 | 30 | 31 | ||||